Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial

BACKGROUND: The benefit of sulfonylureas (SUs) to patients with type 2 diabetes mellitus receiving long-term insulin treatment is unclear. This study evaluated glycemic control and beta-cell function after SU withdrawal in these patients. METHODS: In this 8-week randomized controlled study, patients...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diabetes Metab Syndr Obes
Asıl Yazarlar: Srivanichakorn, Weerachai, Sriwijitkamol, Apiradee, Kongchoo, Aroon, Sriussadaporn, Sutin, Plengvidhya, Nattachet, Lertwattanarak, Raweewan, Vannasaeng, Sathit, Thongtang, Nuntakorn
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2015
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354396/
https://ncbi.nlm.nih.gov/pubmed/25767401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S78008
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller